Breaking: Eli Lilly (NYSE:LLY) Buy Rating Maintained at Jefferies Today; The TP Given is $96

July 17, 2017 - By Peter Erickson

 Breaking: Eli Lilly (NYSE:LLY) Buy Rating Maintained at Jefferies Today; The TP Given is $96

Investors sentiment decreased to 0.97 in Q4 2016. Its down 0.11, from 1.08 in 2016Q3. It turned negative, as 84 investors sold Eli Lilly and Co shares while 380 reduced holdings. 103 funds opened positions while 348 raised stakes. 809.72 million shares or 0.51% more from 805.63 million shares in 2016Q3 were reported.

Stelac Advisory Serv Limited Liability accumulated 0.2% or 8,127 shares. Kanaly Tru stated it has 0.01% of its portfolio in Eli Lilly and Co (NYSE:LLY). Oak Ridge Invests Lc has 171,784 shares for 0.41% of their portfolio. United Svcs Automobile Association owns 469,443 shares for 0.12% of their portfolio. Brown Advisory owns 71,323 shares for 0.02% of their portfolio. Hallmark Management invested in 0.18% or 17,318 shares. State Of Wisconsin Board accumulated 0.32% or 1.02M shares. Fiduciary Trust Co owns 22,141 shares for 0.05% of their portfolio. Visionary Asset Mgmt invested 1.09% of its portfolio in Eli Lilly and Co (NYSE:LLY). Trustmark Bancorporation Tru Department stated it has 17,060 shares. Limited Oh Adv reported 7,467 shares. First Mercantile Trust holds 0.27% or 23,311 shares in its portfolio. Reynders Mcveigh Capital Mgmt Ltd Liability Corp has invested 0.07% in Eli Lilly and Co (NYSE:LLY). 3,002 are held by Country Club Trust Na. Bridgewater Associates L P owns 119,400 shares.

Since February 1, 2017, it had 0 insider purchases, and 9 selling transactions for $59.49 million activity. 230,000 Eli Lilly and Co (NYSE:LLY) shares with value of $18.46 million were sold by LILLY ENDOWMENT INC. Conterno Enrique A had sold 25,000 shares worth $2.07M on Thursday, May 4. $861,085 worth of Eli Lilly and Co (NYSE:LLY) was sold by Rice Derica W. The insider Zulueta Alfonso G sold 15,000 shares worth $1.16M. On Monday, June 12 Barnes Melissa S sold $153,482 worth of Eli Lilly and Co (NYSE:LLY) or 1,900 shares. 2,000 Eli Lilly and Co (NYSE:LLY) shares with value of $155,040 were sold by Zakrowski Donald A.

Eli Lilly (NYSE:LLY) Rating Reaffirmed

In an analyst note sent to investors on 17 July, The Buy rating of Eli Lilly (NYSE:LLY) shares was maintained by Jefferies, who now has a $96 TP on the stock. Jefferies’s TP indicates a possible upside of 14.63 % from the current stock price of the company.

Investors sentiment decreased to 0.97 in Q4 2016. Its down 0.11, from 1.08 in 2016Q3. It turned negative, as 84 investors sold Eli Lilly and Co shares while 380 reduced holdings. 103 funds opened positions while 348 raised stakes. 809.72 million shares or 0.51% more from 805.63 million shares in 2016Q3 were reported.

Stelac Advisory Serv Limited Liability accumulated 0.2% or 8,127 shares. Kanaly Tru stated it has 0.01% of its portfolio in Eli Lilly and Co (NYSE:LLY). Oak Ridge Invests Lc has 171,784 shares for 0.41% of their portfolio. United Svcs Automobile Association owns 469,443 shares for 0.12% of their portfolio. Brown Advisory owns 71,323 shares for 0.02% of their portfolio. Hallmark Management invested in 0.18% or 17,318 shares. State Of Wisconsin Board accumulated 0.32% or 1.02M shares. Fiduciary Trust Co owns 22,141 shares for 0.05% of their portfolio. Visionary Asset Mgmt invested 1.09% of its portfolio in Eli Lilly and Co (NYSE:LLY). Trustmark Bancorporation Tru Department stated it has 17,060 shares. Limited Oh Adv reported 7,467 shares. First Mercantile Trust holds 0.27% or 23,311 shares in its portfolio. Reynders Mcveigh Capital Mgmt Ltd Liability Corp has invested 0.07% in Eli Lilly and Co (NYSE:LLY). 3,002 are held by Country Club Trust Na. Bridgewater Associates L P owns 119,400 shares.

Since February 1, 2017, it had 0 insider purchases, and 9 selling transactions for $59.49 million activity. 230,000 Eli Lilly and Co (NYSE:LLY) shares with value of $18.46 million were sold by LILLY ENDOWMENT INC. Conterno Enrique A had sold 25,000 shares worth $2.07M on Thursday, May 4. $861,085 worth of Eli Lilly and Co (NYSE:LLY) was sold by Rice Derica W. The insider Zulueta Alfonso G sold 15,000 shares worth $1.16M. On Monday, June 12 Barnes Melissa S sold $153,482 worth of Eli Lilly and Co (NYSE:LLY) or 1,900 shares. 2,000 Eli Lilly and Co (NYSE:LLY) shares with value of $155,040 were sold by Zakrowski Donald A.

Eli Lilly and Co (NYSE:LLY) Ratings Coverage

Among 17 analysts covering Eli Lilly and Company (NYSE:LLY), 13 have Buy rating, 1 Sell and 3 Hold. Therefore 76% are positive. Eli Lilly and Company has $125 highest and $64 lowest target. $94.50’s average target is 12.84% above currents $83.75 stock price. Eli Lilly and Company had 56 analyst reports since July 23, 2015 according to SRatingsIntel. The firm earned “Overweight” rating on Friday, December 16 by Morgan Stanley. The rating was upgraded by Goldman Sachs on Tuesday, September 27 to “Buy”. The stock of Eli Lilly and Co (NYSE:LLY) has “Buy” rating given on Thursday, June 22 by Jefferies. The firm has “Market Perform” rating given on Friday, November 25 by BMO Capital Markets. On Monday, December 28 the stock rating was maintained by Leerink Swann with “Outperform”. BMO Capital Markets upgraded it to “Outperform” rating and $100 target in Monday, November 16 report. Barclays Capital upgraded the stock to “Overweight” rating in Tuesday, December 1 report. The firm has “Neutral” rating given on Friday, November 25 by Atlantic Securities. The stock of Eli Lilly and Co (NYSE:LLY) has “Buy” rating given on Tuesday, March 15 by Jefferies. The rating was upgraded by JP Morgan to “Overweight” on Thursday, September 8.

About 1.11M shares traded. Eli Lilly and Co (NYSE:LLY) has risen 4.70% since July 17, 2016 and is uptrending. It has underperformed by 12.00% the S&P500.

Investors wait Eli Lilly and Co (NYSE:LLY) to report on July, 25 before the open. its quarterly earnings Wall Street analysts expect $1.03 earnings per share, up $0.17 or 19.77 % from last year’s $0.86 same quarter earnings. This translates into $1.14B profit for LLY giving the stock a 20.33 P/E. This is assuming the current $1.03 EPS is accurate. Eli Lilly and Co’s Wall Street analysts see 5.10 % EPS growth, taking into account the $0.98 EPS reproted in the previous quarter,

Eli Lilly and Company is engaged in drug manufacturing business. The company has market cap of $92.77 billion. The Firm discovers, develops, makes and markets products in two divisions: human pharmaceutical products and animal health products. It has a 40.67 P/E ratio. The Company’s human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists.

More notable recent Eli Lilly and Co (NYSE:LLY) news were published by: Benzinga.com which released: “Delta, United, Eli Lilly, General Electric: Fast Money Picks For July 13” on July 13, 2017, also Prnewswire.com with their article: “Eli Lilly and Company to Present More Than 40 Abstracts at the Alzheimer’s …” published on July 12, 2017, Fool.com published: “Better Buy: Pfizer Inc. vs. Eli Lilly and Company” on July 01, 2017. More interesting news about Eli Lilly and Co (NYSE:LLY) were released by: Streetinsider.com and their article: “Eli Lilly & Co. (LLY) Reports Settlement Agreement in US Cialis Patent Litigation” published on July 12, 2017 as well as Marketwatch.com‘s news article titled: “Eli Lilly settlement will result in Cialis patent expiring as early as 2018 …” with publication date: July 12, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.